If programmable CRISPR protocols allow a lab to go from patient biopsy to edited pluripotent line and differentiated cells in a matter of weeks, those oversight mechanisms will need to adapt so they ...
In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
At the height of the COVID-19 pandemic in 2020, Marvin Collins ’22, a bioengineering student, was balancing their Stanford classes from home in Alabama while also helping bioengineering professor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results